Website Search
ID 1173

Glutamate and Schizophrenia

Professor Daniel Weinberger discusses evidence from a number of research areas that highlight the importance of the neurotransmitter glutamate in schizophrenia.
So how does glutamate relate to schizophrenia? For probably forty years, most of the work on schizophrenia was focused on dopamine. But because the evidence has increasingly centered around areas of the brain like the frontal lobe and the hippocampus, which are the so-called cortical regions of the brain, there’s been a lot more interest in what are the neurotransmitters that are critical for how the cortex works. And in the cortex, the main neurotransmitters are amino acid neurotransmitters like glutamate and GABA. Glutamate is the principle neurotransmitter of cells that communicate across long distances in the brain. Such as across cortical regions and from the cortex down into the spinal cord or out into the rest of your body. And glutamate is a critical molecule for the function of the cortex. Based on those observations, there’s been a lot of research to look at glutamate. And there’s a pharmacological model of schizophrenia based on the blocking of certain glutamate receptors, a particular glutamate receptor called the NMDA receptor, which is the N-methyl-D-aspartate receptor. There’s a drug, a street drug, called PCP which blocks this receptor. Associated with the use of this drug is a psychotic-like state – not just a psychotic state but also change in cognitive function, change in the ability to pay attention, distraction which have certain features of schizophrenia. So there’s been a pharmacological model of schizophrenia based on glutamate. Turns out, so far, most of the genes that have been found that relate to schizophrenia, particularly neuregulin, dysbindin, COMT – some other genes like GRM3, AKT1, calcineurin, etc. – many of these genes seem to impact on the function of glutamate in the brain. So glutamate might be a final common pathway that many of the biological risk factors impact upon to translate into the kind of behavior and brain function we see in schizophrenia.
schizophrenia, glutamate, receptor, neurotransmitter, neurotransmission, nmda, hippocampus, pcp, daniel, weinberger
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

1182. Glutamate Hypothesis of Schizophrenia
Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms.
2226. Schizophrenia
An overview of schizophrenia-related content on Genes to Cognition Online.
510. GRM3 Gene
Metabotropic Glutamate Receptor-3 (GRM3) is a candidate gene for schizophrenia.
1211. What is NMDA?
Professor Seth Grant explains that NMDA is an amino acid derivative very similar to glutamate - the brain's primary excitatory neurotransmitter.
811. The Glutamate System
Professor Trevor Robbins describes some of the key functions of the excitatory glutamate system, which is integral to information processing and long-term potentiation.
1734. NR1/A0001
NR1 is the obligatory subunit of NMDA receptors.
1169. COMT expression
Professor Daniel Weinberger explains that the schizophrenia candidate gene, COMT, is abundantly expressed in the hippocampus and prefrontal cortex.
1165. Dopamine and Schizophrenia
Professor Daniel Weinberger explains that dopamine is the major focus of biochemical research into schizophrenia.
923. DAOA/G72
Polymorphisms of DAOA are associated with schizophrenia and bipolar disorder risk.
868. Candidate Genes for Schizophrenia
An interactive chromosome map of the genes and loci associated with schizophrenia.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving